Home › Funds › SymBiosis Capital Partners, LLC › CLNN
SymBiosis Capital Partners, LLC position in CLNN
Clene Inc · Health Care
SymBiosis Capital Partners, LLC reported holding 431,094 shares of CLNN (Clene Inc) in its Q1 2026 13F filing — a position valued at US$2.1M, representing 4.03% of its reported portfolio and ranking #5 among its reported holdings. SymBiosis Capital Partners, LLC has disclosed CLNN holdings in 2 of the last 2 reported quarters, going back to Q4 2025.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How SymBiosis Capital Partners, LLC's CLNN position evolved
SymBiosis Capital Partners, LLC first disclosed a stake in CLNN in Q4 2025 at 770,495 shares (US$4.5M). Across 2 filings, SymBiosis Capital Partners, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q1 2026) shows 431,094 shares valued at US$2.1M — a reduction of -339,401 shares quarter over quarter.. Notable position changes include a 44% trim in Q1 2026 (shares rose 25% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 770.50K | $4.52M | New |
| Q1 2026 | 431.09K | $2.13M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CLNN and 13F data
CLNN (Clene Inc) is a Health Care company. 29 other funds we track also report a position in CLNN — the largest reported positions include Empery Asset Management, LP (US$5.6M), SCOGGIN MANAGEMENT LP (US$3.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CLNN
- Empery Asset Management, LP 916.53K sh · $5.64M · Q2 2026
- SCOGGIN MANAGEMENT LP 600.00K sh · $3.69M · Q2 2026
More on SymBiosis Capital Partners, LLC
FAQ
How long has SymBiosis Capital Partners, LLC held CLNN?
SymBiosis Capital Partners, LLC has disclosed CLNN holdings in 2 of the last 2 reported quarters, going back to Q4 2025.
What is SymBiosis Capital Partners, LLC's current position in CLNN?
As of Q1 2026, SymBiosis Capital Partners, LLC holds 431.09K shares of CLNN (Clene Inc), valued at $2.13M, representing 4.03% of its reported portfolio and ranking #5.
Has SymBiosis Capital Partners, LLC been buying or selling CLNN?
In the latest 13F filing (Q1 2026), SymBiosis Capital Partners, LLC reduced its position in CLNN.
Which other funds hold CLNN?
Other major institutional holders of CLNN include Empery Asset Management, LP, SCOGGIN MANAGEMENT LP, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.